This provider's $18.7M in total Medicare payments ranks in the 99th percentile of Centralized Flu providers nationally.
Medicare payments to this provider grew 162% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 270% in 2021
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $30.95 | $27.42 | 1.13x | $3.53 | $1.3M | 48.7K | 9 |
| 2015 | $39.37 | $38.33 | 1.03x | $1.04 | $1.9M | 49.8K | 8 |
| 2016 | $36.22 | $35.45 | 1.02x | $0.77 | $1.3M | 36.9K | 8 |
| 2017 | $42.33 | $38.94 | 1.09x | $3.39 | $1.5M | 39.0K | 7 |
| 2018 | $41.70 | $38.09 | 1.09x | $3.61 | $1.3M | 35.0K | 7 |
| 2019 | $40.90 | $36.78 | 1.11x | $4.12 | $881.8K | 24.0K | 10 |
| 2020 | $41.37 | $39.84 | 1.04x | $1.53 | $881.5K | 22.1K | 9 |
| 2021 | $39.34 | $38.55 | 1.02x | $0.79 | $3.3M | 84.6K | 16 |
| 2022 | $28.04 | $26.72 | 1.05x | $1.32 | $2.8M | 104.1K | 17 |
| 2023 | $42.92 | $40.74 | 1.05x | $2.18 | $3.5M | 85.9K | 13 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 90662 | Influenza vaccine split virus, preservative free | 129.8K | $6.5M | $49.96 | 1.05x |
| G0008 | Administration of influenza virus vaccine | 157.8K | $3.5M | $21.93 | 1.12x |
| 90670 | Pneumococcal vaccine for injection into muscle | 7.5K | $1.3M | $175.43 | 1.02x |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | 25.2K | $1.0M | $39.78 | 1.01x |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | 6.8K | $973.8K | $143.00 | 1.06x |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 87.6K | $858.8K | $9.80 | 1.02x |
| 0004A | Adm sarscov2 30mcg/0.3ml bst | 16.7K | $666.3K | $39.94 | 1.00x |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | 9.9K | $570.3K | $57.46 | 1.03x |
| 91320 | Sarscv2 vac 30mcg trs-suc im | 3.6K | $469.0K | $128.48 | 1.15x |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | 9.3K | $360.5K | $38.88 | 1.03x |
| 90480 | Admn sarscov2 vacc 1 dose | 10.5K | $327.9K | $31.35 | 1.02x |
| 90732 | Pneumococcal vaccine, 23-valent | 3.4K | $325.3K | $96.03 | 1.02x |
| 0012A | Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; second dose | 6.5K | $248.6K | $38.47 | 1.00x |
| 0134A | Adm sarscv2 bvl 50mcg/.5ml a | 5.6K | $218.9K | $38.82 | 1.03x |
| G0009 | Administration of pneumococcal vaccine | 10.2K | $191.6K | $18.80 | 1.04x |
| 0051A | Adm sarscv2 30mcg trs-sucr 1 | 4.4K | $170.9K | $38.84 | 1.02x |
| 0011A | Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; first dose | 6.7K | $170.9K | $25.57 | 1.28x |
| 0003A | Fee covid-19 vac 1 booster | 4.0K | $159.0K | $39.97 | 1.00x |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | 8.5K | $148.7K | $17.55 | 1.09x |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 444 | $124.0K | $279.17 | 1.02x |
This provider submits charges 1.06 times higher than what Medicare actually pays.
A markup ratio of 1.06x means for every $100 Medicare pays, this provider initially charges $106. This is lower than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data